Precog, Llc.
Clinical trials sponsored by Precog, Llc., explained in plain language.
-
New drug combo aims to boost immune attack on tough lung cancer
Disease control Recruiting nowThis study tests a new drug called ivonescimab, given with standard chemotherapy, for people with extensive-stage small cell lung cancer who haven't had treatment yet. Ivonescimab is a special antibody that helps the immune system fight cancer and may also block blood vessels tha…
Phase: PHASE2 • Sponsor: PrECOG, LLC. • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
Real-World study tracks osimertinib combo for lung cancer
Knowledge-focused Recruiting nowThis study is watching how patients with EGFR-mutated non-small cell lung cancer do when they receive standard treatment with osimertinib (Tagrisso) alone or with chemotherapy in routine medical practice. About 538 people with advanced lung cancer will be followed to see how long…
Sponsor: PrECOG, LLC. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC